• 1. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 2. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles Benzimidazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles

Introduction to {1-(2-chlorophenyl)methyl-1H-1,3-benzodiazol-2-yl}methanol (CAS No. 341021-39-4)

{1-(2-chlorophenyl)methyl-1H-1,3-benzodiazol-2-yl}methanol} is a significant compound in the field of pharmaceutical chemistry, characterized by its complex molecular structure and potential therapeutic applications. This compound, identified by the CAS number 341021-39-4, has garnered attention due to its structural similarity to certain bioactive molecules, making it a subject of interest for further research and development.

The molecular framework of {1-(2-chlorophenyl)methyl-1H-1,3-benzodiazol-2-yl}methanol incorporates a benzodiazole core, which is well-known for its role in various pharmacological activities. The benzodiazole moiety is a crucial pharmacophore in many central nervous system (CNS) drugs, exhibiting properties such as anxiolytic, sedative, and muscle relaxant effects. The presence of a 2-chlorophenyl group and a methanol substituent further enhances the compound's potential for interaction with biological targets.

Recent advancements in medicinal chemistry have highlighted the importance of structural modifications in developing novel therapeutic agents. The compound {1-(2-chlorophenyl)methyl-1H-1,3-benzodiazol-2-yl}methanol represents an excellent candidate for such studies due to its unique structural features. Researchers have been exploring its potential in various pharmacological assays to evaluate its efficacy and safety profiles.

In vitro studies have demonstrated that {1-(2-chlorophenyl)methyl-1H-1,3-benzodiazol-2-yl}methanol exhibits promising interactions with specific enzymes and receptors. These interactions are critical for understanding its mechanism of action and for identifying potential therapeutic applications. For instance, the compound has shown affinity for certain serotonergic receptors, which are implicated in the regulation of mood and anxiety disorders.

The synthesis of {1-(2-chlorophenyl)methyl-1H-1,3-benzodiazol-2-yl}methanol involves multi-step organic reactions that require precise control over reaction conditions. The chlorophenyl group introduces electronic and steric effects that influence the compound's reactivity and binding properties. Advanced synthetic techniques have been employed to optimize the yield and purity of this compound, ensuring its suitability for further pharmacological investigations.

One of the key areas of research focused on {1-(2-chlorophenyl)methyl-1H-1,3-benzodiazol-2-yl}methanol is its potential role in treating neurological disorders. The benzodiazole core is known to modulate GABAergic neurotransmission, which is a critical pathway involved in the regulation of neuronal excitability. By targeting this pathway, the compound may offer therapeutic benefits in conditions such as epilepsy, seizures, and sleep disorders.

Additionally, the structural features of {1-(2-chlorophenyl)methyl-1H-1,3-benzodiazol-2-yl}methanol make it an attractive scaffold for designing new drugs with improved pharmacokinetic properties. Researchers are investigating ways to optimize its solubility, bioavailability, and metabolic stability through structural modifications. These efforts are aimed at enhancing the compound's therapeutic efficacy while minimizing potential side effects.

The impact of {1-(2-chlorophenyl)methyl-1H-1,3-benzodiazol-2-yl}methanol on drug development is further underscored by its potential as a lead compound for new therapeutics. By leveraging computational modeling and high-throughput screening techniques, scientists can rapidly assess the compound's interactions with biological targets and identify derivatives with enhanced activity. This approach accelerates the discovery process and contributes to the development of novel pharmaceuticals.

In conclusion, {1-(2-chlorophenyl)methyl-1H-1,3-benzodiazol-2-yl}methanol (CAS No. 341021-39-4) is a versatile compound with significant potential in pharmaceutical research. Its unique molecular structure and bioactive properties make it a valuable candidate for further exploration in drug discovery. As research continues to uncover new applications for this compound, it is expected to play a crucial role in the development of innovative therapies for various diseases.

• 193013-85-3(1-[(2,4-dichlorophenyl)methyl]-2-methyl-1H-1,3-benzodiazole)
• 428856-23-9({1-(4-methylphenyl)methyl-1H-1,3-benzodiazol-2-yl}methanol)
• 1420863-16-6((3-(2-Chlorobenzyl)-3H-imidazo[4,5-b]pyridin-2-yl)methanol)
• 193013-48-8(1H-BENZIMIDAZOLE-6-METHANOL, 1-[(2-CHLOROPHENYL)METHYL]-2-METHYL-)
• 6646-70-4((1-Benzyl-1H-benzimidazol-2-yl)methanol)
• 64905-87-9(1H-[1,4]Oxazino[4,3-a]benzimidazole, 7-chloro-3,4-dihydro-8-methyl-)
• 5652-60-8(1-(4-Chlorobenzyl)-1H-benzimidazol-2-ylmethanol)
• 500149-05-3({1-(2,4-dichlorophenyl)methyl-1H-1,3-benzodiazol-2-yl}methanol)
• 7187-31-7({1-[(4-chlorophenyl)methyl]-1H-1,3-benzodiazol-2-yl}methanol)
• 537010-38-1(1-[(2-chlorophenyl)methyl]-1H-1,3-benzodiazole-2-carbaldehyde)